Search

everythinglearnresearchcommunity

for

Search:↓

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Most patients stop using topical minoxidil due to side effects.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Knowing about finasteride's sexual side effects increases reported dysfunction.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.

Finasteride and dutasteride increase sexual dysfunction reports.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Using finasteride with TIP extends time off period for prostate cancer patients.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.